IUPUI Research Could Change Treatment for Some TBIs

Posted: Updated:
Blazer-Yost says a failed hypothesis during her kidney research uncovered the potential treatment for hydrocephalus. Blazer-Yost says a failed hypothesis during her kidney research uncovered the potential treatment for hydrocephalus.

The Department of Defense has tapped a team of researchers at IUPUI to lead a mission that is critical to the health of U.S. troops. The scientists are working to create a drug to treat hydrocephalus, a condition that often occurs after traumatic brain injury (TBI), which is an increased area of focus for the military due to its high rate of TBIs. The only current treatment for hydrocephalus is brain surgery—an unlikely option during deployment—so the DoD awarded the researchers a nearly $2 million grant to lead the charge for a different battle plan.

The military’s Defense and Veterans Brain Injury Center says more than 375,000 service members have suffered a TBI since 2000; the last few years have posted annual averages that hover around 20,000 TBIs, and the vast majority of those occur during active duty.

Hydrocephalus, often called “water on the brain,” is caused by cerebrospinal fluid buildup in the skull that makes the brain swell, which can lead to brain damage. IUPUI School of Science Biology Professor Dr. Bonnie Blazer-Yost says data suggests anywhere from 10 to 50 percent of people who sustain a TBI develop post-traumatic hydrocephalus due to inflammation in the brain.

“I think the reason we don’t have good data is, to determine that [you have hydrocephalus], you have to do MRIs, which are expensive and require being near a major medical facility that has that type of equipment,” says Blazer-Yost, the grant’s principal investigator. “So we really don’t know the prevalence of post-traumatic hydrocephalus, but we know it’s a problem.”

The standard treatment for hydrocephalus is brain surgery to insert a shunt that directs the excess fluid elsewhere in the body—a procedure that can be difficult to execute in active military zones. Children born prematurely may also develop hydrocephalus due to brain bleeds. Blazer-Yost says, in these long-term cases, children may undergo many surgeries, because the shunts have a 50 percent failure rate after three years.

The research team has discovered a promising compound that could be an alternative to surgery. It blocks a particular electrolyte channel that’s important for the production of cerebrospinal fluid; in her lab, inhibiting a particular electrolyte transporter reduces hydrocephalus in an animal model.

Blazer-Yost says she stumbled upon the discovery. For many years, her primary focus has been polycystic kidney disease; the compound she’d developed to treat that disease failed, and instead, she uncovered a different application for hydrocephalus.

“Sometimes, a failed hypothesis is a lot more interesting than proving your hypothesis. And in this case, it was, indeed, a failed hypothesis,” laughs Blazer-Yost. “Those of us who have been in science for 30-odd years—you get used to this. I always tell my students, particularly my grad students, don’t become too attached to your hypotheses, because they could be wrong.”

The $1.8 million DoD grant will enable the team, which has been collaborating for several years, to perform more costly and elaborate experiments to further test its compound that could potentially lead to the first non-surgical treatment for hydrocephalus.

In addition to TBI patients and premature infants, such a drug could also help the aging population. Blazer-Yost says one of the most under-diagnosed forms of hydrocephalus occurs in this segment of patients, because it mimics other signs of aging, such as difficulty walking, incognance and dementia.

“There’s a decent incidence of hydrocephalus in Parkinson’s disease, and there are some questions as to whether it might also occur in Alzheimer’s disease,” says Blazer-Yost. “It’s part of a number of different diseases, and I think it’s been more recently recognized.”

Blazer-Yost says the military, especially, is interested in helping soldiers fully recover from TBIs. She acknowledges “it’s a very long way” from the lab to a final drug, but says her team is mission-minded and steadily marching toward that goal. 

Blazer-Yost says the military is interested in any treatment that could help service members fully heal from TBIs.
Blazer-Yost says the ultimate goal is to develop a drug to treat hydrocephalus that could be used “as needed.”
  • Perspectives

    • #MeToo, Bullying And What We All Can Do Now

      Indeed, it is an interesting time with so much continuing to come out in Hollywood, the media, other industries, and even our state government related to the sexual harassment of women - women who have remained silent for years. Like those women, I too have been harassed in various ways over the course of my career, even in recent years - and yes, even in top leadership roles. The headline about my departure or the email citing that I was moving on never fully told the real story.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Maggie Galloway accepted the top prize for Inscope Medical. (Picture Courtesy: inX3)

      Organizers Cancel INX Event

      A multi-day event celebrating Indiana innovation that debuted last year will not return this year. In a joint release, INX organizer inXInnovate LTD and the Venture Club of Indiana say INX, originally scheduled for September 18-19 in Indianapolis, has been canceled. The groups cite "unforeseen circumstances" for the cancellation. Last year's event, which took place at The Union 525 in downtown Indianapolis, featured events including the Venture Club's...

    • Elkhart Industries 'Beyond Just The RV Market'

      While Elkhart County is known as the Recreational Vehicle Capital of the World, companies in more diversified sectors are also enjoying significant growth. "I think (the economy) is a little stronger than people might realize and it's beyond just the RV market," Welch Packaging Chief Executive Officer Scott Welch said during an Elkhart Town Hall edition of Inside INdiana Business With Gerry Dick. His company manufactures custom corrugated boxes and he was joined by...

    • Salesforce Begins Pathfinder, Reorganization Efforts

      Salesforce.com Inc. (NYSE: CRM) is underway with the first cohort of its Pathfinder Training Program that is part of the tech giant's ongoing Indianapolis growth. The company is partnering with Deloitte to provide business and technical training to Ivy Tech Community College students and Hoosier veterans looking to become Salesforce administrators and developers. The program comes as the company realigns its Marketing Cloud organization. In a statement, Salesforce says it...

    • Ed Gebhart

      Fadness Appoints Gebhart Chief of Police

      Fishers Mayor Scott Fadness has appointed Assistant Chief Ed Gebhart to chief of police for the city of Fishers. He has been with Fishers Police Department since 2000. Gebhart has held several ranks during his tenure including patrol officer, field training officer, background investigator, sergeant, director of training, patrol commander, followed by his most recent role as assistant chief in 2016. He holds a Bachelor of Science degree in Criminal Justice.

    • Fort Wayne Radio Icon Butcher Passes Away

      A fixture in the Fort Wayne radio scene has passed away. Charly Butcher spent more than 30 years in Fort Wayne radio with a successful morning show on WMEE-FM and, most recently, as host of "Fort Wayne's Morning News" on WOWO radio. Butcher was 61. Butcher was part of WMEE's popular "Those Two Guys In The Morning" show with Tony Richards in the 1980s. He joined WOWO in the mid-2000s as host of "Fort Wayne's Morning News With Charly Butcher."